Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 427 entries
View as:

Efficacy of Oral Azacitidine Plus Best Supportive Care as Maintenance Therapy in Subjects With Acute Myeloid Leukemia (AML) in Complete Remission

Phase: N/A Priority: Normal
NCT ID: NCT01757535 Org: User:
Start: 04/24/13 End: 06/18/24 Due: 06/18/25

Non-interventional Study of Lenalidomide in the Clinical Routine Treatment of TD Patients With IPSS Low or Int-1 MDS and Isolated Del(5q)

Phase: N/A Priority: Normal
NCT ID: NCT02279654 Org: User:
Start: 12/17/14 End: 03/29/22 Due: 03/29/23

A Phase II Study of Single-Agent Lenalidomide in Subjects With Relapsed Or Refractory T-Cell Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00655668 Org: User:
Start: 03/01/08 End: 04/01/10 Due: 04/01/11

A Phase 2 Study of Lenalidomide to Evaluate the Efficacy in Japanese Patients With Newly Diagnosed Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT01698801 Org: User:
Start: 10/01/12 End: 06/26/18 Due: 06/26/19

Efficacy and Safety Study of CC-4047 (Pomalidomide) to Treat Advanced Soft Tissue Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT00717522 Org: User:
Start: 08/01/08 End: 01/01/09 Due: 01/01/10

Study of the Safety and Efficacy of CC-5013 Treatment For Patients With Myelodysplastic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00044382 Org: User:
Start: 02/01/02 End: 01/30/07 Due: 01/30/08

An Open Label Study in Patients With Advanced NSCLC With ABI-007(Abraxane) in Combination With Carboplatin

Phase: N/A Priority: Normal
NCT ID: NCT00274443 Org: User:
Start: 03/01/05 End: 06/01/07 Due: 06/01/08

A Study to Determine Final Geriatric Assessment in Haematology (GAH) Score as a Tool for Predicting Tolerance to Treatment in Elderly Patients (≥ 65 Years) With Haematologic Neoplasms

Phase: N/A Priority: Normal
NCT ID: NCT02842229 Org: User:
Start: 07/20/16 End: 02/02/17 Due: 02/02/18

Study of Marizomib With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Brain Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02903069 Org: User:
Start: 08/17/16 End: 01/25/21 Due: 01/25/22

Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia

Phase: N/A Priority: Normal
NCT ID: NCT01351935 Org: User:
Start: 07/18/11 End: 06/26/15 Due: 06/26/16

A Safety and Efficacy Study of CC-90009 Combinations in Subjects With Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT04336982 Org: User:
Start: 08/05/20 End: 04/05/24 Due: 04/05/25

Drug-drug Interaction Study of Ozanimod With Tyramine to Evaluate the Effect on Pressor Response

Phase: N/A Priority: Normal
NCT ID: NCT03694119 Org: User:
Start: 07/24/18 End: 01/08/19 Due: 01/08/20

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Phase: N/A Priority: Normal
NCT ID: NCT01081015 Org: User:
Start: 03/19/10 End: 12/31/17 Due: 12/31/18

To Document the Burden of Illness on the Quality of Life and the Impact on Healthcare Utilization in (Beta) β-thalassemia Subjects Who Are Transfusion Dependent (TD) and Non-transfusion Dependent (NTD) Receiving Standard of Care

Phase: N/A Priority: Normal
NCT ID: NCT02626689 Org: User:
Start: 03/01/16 End: 01/03/17 Due: 01/03/18

A Phase 1 Open-Label Study to Evaluate the Effect of CYP450 and P-gp Inhibition and Induction on the Pharmacokinetics of Pomalidomide (CC-4047) in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01707407 Org: User:
Start: 09/01/12 End: 11/01/12 Due: 11/01/13

Safety Study of Lenalidomide With and Without Dexamethasone in Japanese Subjects With Previously Treated Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00555100 Org: User:
Start: 07/01/07 End: 12/01/10 Due: 12/01/11

Expanded Access for ACE-011

Phase: N/A Priority: Normal
NCT ID: NCT03724227 Org: User:
Start: - End: - Due: -

Radiolabeled Study of CC-122 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02234999 Org: User:
Start: 09/23/14 End: 10/08/14 Due: 10/08/15

Individual Patient Compassionate Use of Fedratinib

Phase: N/A Priority: Normal
NCT ID: NCT03723148 Org: User:
Start: - End: - Due: -

A Study to Assess the Pharmacokinetics of Enasidenib (CC-90007) in Subjects With Moderate and Severe Hepatic Impairment.

Phase: N/A Priority: Normal
NCT ID: NCT03290443 Org: User:
Start: 09/21/17 End: 10/26/18 Due: 10/26/19

A Study of Luspatercept (ACE-536) to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes

Phase: N/A Priority: Normal
NCT ID: NCT02631070 Org: User:
Start: 02/09/16 End: 11/26/20 Due: 11/26/21

A Study to Determine Safety, Feasibility and Efficacy of JCAR015 in Adult Subjects With B-Cell Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT02973191 Org: User:
Start: 12/20/16 End: 01/24/21 Due: 01/24/22

Pharmacogenetics Sampling of the CC-90007-CP-003 Study Cohort

Phase: N/A Priority: Normal
NCT ID: NCT04097704 Org: User:
Start: 09/04/19 End: 11/01/19 Due: 11/01/20

An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Subjects With Myeloproliferative Neoplasm-Associated Myelofibrosis on Concomitant JAK2 Inhibitor Therapy and Who Require Red Blood Cell Transfusions

Phase: N/A Priority: Normal
NCT ID: NCT04717414 Org: User:
Start: 02/25/21 End: 08/18/32 Due: 08/18/33

Continuation Trial Evaluating the Tolerability and Activity of FK228 in Patients That Completed Prior Study With FK228

Phase: N/A Priority: Normal
NCT ID: NCT00106301 Org: User:
Start: 04/01/04 End: 09/01/06 Due: 09/01/07